跳至主要内容
临床试验/IRCT20200506047323N5
IRCT20200506047323N5招募中3 期

Evaluation of the efficacy and safety of Melatonin in patients with COVID-19: a randomized clinical trial

Bandare-abbas University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 no limit(—)
性别
All

入选标准

  • Age >20 years
  • Positive polymerase chain reaction (PCR) test for COVID-19 or/and lung involvement in imaging
  • Primary clinical symptoms
  • Hospitalized and moderate patients
  • Signing informed consent and willingness of study participant to accept randomization to any assigned treatment arm

排除标准

  • Patients with underlying diseases including hypertension, diabetes, seizure, depression, chronic hepatitis, cirrhosis, and cholestatic liver diseases
  • Use of anticoagulant drugs like warfarin, hormonal drugs, alcohol, and any illegal drugs (during last 30 days)
  • History of allergy to Melatonin
  • Pregnancy and breastfeeding

研究者

发起方
Bandare-abbas University of Medical Sciences

相似试验